{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:48:07Z","timestamp":1780102087362,"version":"3.54.0"},"reference-count":20,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that may be difficult to diagnose and treat. We presented a 41-year-old woman who required skin grafting following third-degree burns to her left breast. She suffered recurrent graft dehiscence and infections over many years, prompting elective bilateral reduction mammoplasty. She subsequently developed suture margin ulcerations unresponsive to topical therapies and antibiotics. Skin biopsies were non-specific, and a clinical diagnosis of PG was established. Although initially responsive to corticosteroids, wounds promptly recurred following steroid taper. She was treated unsuccessfully with various immunomodulatory agents and underwent elective bilateral mastectomy. Following a mastectomy, she developed progressive deep chest wall ulcerations. She failed numerous immunomodulatory treatments, surgical wound closure and negative pressure wound therapy. Ultimately, treatment with adalimumab, mycophenolate mofetil and prednisone, in addition to hyperbaric oxygen therapy facilitated progressive healing. Our case highlights the role of collaborative multimodal therapy for the treatment of refractory PG.<\/jats:p>","DOI":"10.1136\/bcr-2013-201084","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T12:39:33Z","timestamp":1382531973000},"page":"bcr2013201084","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapy"],"prefix":"10.1136","volume":"2013","author":[{"given":"Faiza","family":"Fakhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehrish","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Deitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/BOR.0b013e328341152f","article-title":"Pyoderma gangraenosum","volume":"2013","author":"Wollina","year":"2011","journal-title":"Curr Opin in Rheumatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"2013","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.3","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.08217.x","article-title":"Treatment of pyoderma gangrenosum with intravenous immunoglobulin","volume":"2013","author":"Cummins","year":"2007","journal-title":"Br J Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.4","first-page":"64","article-title":"Pyoderma gangrenosum of the breast treated with intravenous immunoglobulin","volume":"2013","author":"Sinnya","year":"2013","journal-title":"J Dermatol Case Rep"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00128071-200203030-00002","article-title":"Clinical management of pyoderma gangrenosum","volume":"2013","author":"Wollina","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.6","first-page":"1214","article-title":"Pyoderma gangrenosum: dermatologic application of hyperbaric oxygen therapy","volume":"2013","author":"Tutrone","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.7","first-page":"127","article-title":"Gauze-based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum?","volume":"2013","author":"Fraccalvieri","year":"2012","journal-title":"Int Wound J"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.8","doi-asserted-by":"crossref","first-page":"24e","DOI":"10.1097\/01.prs.0000200776.13868.02","article-title":"Managing pyoderma gangrenosum: a synergistic approach combining surgical debridement, vacuum-assisted closure, and hyperbaric oxygen therapy","volume":"2013","author":"Niezgoda","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.9","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.bjps.2010.07.022","article-title":"Pyoderma gangrenosum of the breast: a diagnosis not to be missed","volume":"2013","author":"Duval","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00266-012-9981-3","article-title":"Postsurgical pyoderma gangrenosum complicating reduction mammaplasty","volume":"2013","author":"Grillo","year":"2012","journal-title":"Aesthet Plast Surg"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.11","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1177\/000313481107700707","article-title":"Pyoderma gangrenosum of the breast after bilateral simple mastectomies for ductal carcinoma in situ","volume":"2013","author":"Leppard","year":"2011","journal-title":"Am Surg"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"2013","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"2013","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajmg.c.30267","article-title":"Beckwith-Wiedemann syndrome","volume":"2013","author":"Choufani","year":"2010","journal-title":"Am J of Med Genet Part C Semin Medical Genet"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.15","doi-asserted-by":"crossref","unstructured":"Segaran A Mohammad M Sterling JC . Pyoderma gangrenosum arising in a breast reduction scar: seven years post-procedure. J Plast Reconstr Aest Surg. Published Online First: 4 Jun 2013. doi:10.1016\/j.bjps.2013.05.016","DOI":"10.1016\/j.bjps.2013.05.016"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1090820X10366011","article-title":"A novel approach to the management of pyoderma gangrenosum complicating reduction mammaplasty","volume":"2013","author":"Goshtasby","year":"2010","journal-title":"Aesthet Surg J"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-4632.2007.03286.x","article-title":"Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series","volume":"2013","author":"Charles","year":"2007","journal-title":"Int J Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-4632.2008.03412.x","article-title":"Pyoderma gangrenosum\u2014rebel without a cure","volume":"2013","author":"Jacob","year":"2008","journal-title":"Int J Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2133.2005.06467.x","article-title":"Systemic pyoderma gangrenosum responding to infliximab and adalimumab","volume":"2013","author":"Hubbard","year":"2005","journal-title":"Br J Dermatol"},{"key":"2025042709313984000_2013.oct23_1.bcr2013201084.20","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJM199606203342506","article-title":"Hyperbaric-oxygen therapy","volume":"2013","author":"Tibbles","year":"1996","journal-title":"N Engl J Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-201084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T16:31:51Z","timestamp":1745771511000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-201084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":20,"alternative-id":["10.1136\/bcr-2013-201084"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-201084","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]}}}